Current Location:home > Detailed Browse

Article Detail

2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors

Abstracts

A series of 2-aminopyrimidine derivatives were designed and synthesized as highly selective FGFR4 inhibi-tors. One of the most promising compounds 2n tightly bound FGFR4 with a Kd value of 3.3 nM and potently inhibited its enzymatic activity with an IC50 value of 2.6 nM, but completely spared FGFR1/2/3. The compound selectively suppressed proliferation of breast cancer cells harboring dysregulated FGFR4 signaling with an IC50 value of 0.38 μM. Furthermore, 2n exhibited extraordinary target specificity in a Kinome-wide screen against 468 kinases, with S(35) and S(10) selectivity scores of 0.01 and 0.007 at 1.0 μM, respectively.
Download Comment Hits:5909 Downloads:1146
Recommended references: Mo, Cheng.(2020).2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors.[ChinaXiv:201711.02435] (Click&Copy)
Version History
[V1] 2020-11-24 18:10:06 chinaXiv:201711.02435V1 Download
Related Paper

Download

Current Browse

Change Subject Browse

Cross Subject Browse

  • - NO